Filana Therapeutics (FLNA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.70, -7.43% vs the prior close of $0.76.
- Volume 327.93K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
FLNA slides 7.4% to $0.70, a 1-month low. Closed at $0.70, -7.43% vs the prior close of $0.76. Day range $0.70β$0.76, opened at $0.75.
FLNA daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β FLNA slides 7.4% to $0.70, a 1-month low
- Closed at $0.70, -7.43% vs the prior close of $0.76. Day range $0.70β$0.76, opened at $0.75.
- Volume was 327.93K shares, 0.1x its 50-day average of 2.50M β lighter than usual.
- Price is -17.6% vs its 50-day average ($0.85) and -50.8% vs its 200-day average ($1.43).
- 52-week range $0.67β$4.98; today's close sits at 1% of that range, 85.9% below the 52-week high.
Oct 15, 2026 β FLNA jumps 4.1% to $0.76
- Closed at $0.76, +4.11% vs the prior close of $0.73. Day range $0.70β$0.77, opened at $0.71.
- Volume was 248.50K shares, 0.1x its 50-day average of 2.50M β lighter than usual.
- Price is -11.5% vs its 50-day average ($0.86) and -47.1% vs its 200-day average ($1.44).
- 52-week range $0.67β$4.98; today's close sits at 2% of that range, 84.7% below the 52-week high.
Oct 14, 2026 β FLNA dips 1.4% to $0.73, 3 down days in a row
- Closed at $0.73, -1.35% vs the prior close of $0.74. Day range $0.72β$0.74, opened at $0.73.
- Volume was 253.20K shares, 0.1x its 50-day average of 2.51M β lighter than usual.
- Price is -15.4% vs its 50-day average ($0.86) and -49.4% vs its 200-day average ($1.44).
- 52-week range $0.67β$4.98; today's close sits at 1% of that range, 85.3% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 β FLNA slides 3.9% to $0.74
- Closed at $0.74, -3.90% vs the prior close of $0.77. Day range $0.74β$0.77, opened at $0.76.
- Volume was 323.50K shares, 0.1x its 50-day average of 2.51M β lighter than usual.
- Price is -14.7% vs its 50-day average ($0.87) and -49.0% vs its 200-day average ($1.45).
- 52-week range $0.67β$4.98; today's close sits at 2% of that range, 85.1% below the 52-week high.
Oct 12, 2026 β FLNA slides 6.1% to $0.77
- Closed at $0.77, -6.10% vs the prior close of $0.82. Day range $0.76β$0.81, opened at $0.81.
- Volume was 360.40K shares, 0.1x its 50-day average of 2.50M β lighter than usual.
- Price is -11.9% vs its 50-day average ($0.87) and -47.2% vs its 200-day average ($1.46).
- 52-week range $0.67β$4.98; today's close sits at 2% of that range, 84.5% below the 52-week high.
Oct 9, 2026 β FLNA rises 1.2% to $0.82
- Closed at $0.82, +1.23% vs the prior close of $0.81. Day range $0.80β$0.84, opened at $0.82.
- Volume was 407.90K shares, 0.2x its 50-day average of 2.50M β lighter than usual.
- Price is -6.6% vs its 50-day average ($0.88) and -44.0% vs its 200-day average ($1.47).
- 52-week range $0.67β$4.98; today's close sits at 3% of that range, 83.5% below the 52-week high.
Oct 8, 2026 β FLNA dips 1.2% to $0.81, 5 down days in a row
- Closed at $0.81, -1.22% vs the prior close of $0.82. Day range $0.78β$0.82, opened at $0.80.
- Volume was 610.80K shares, 0.2x its 50-day average of 2.50M β lighter than usual.
- Price is -8.1% vs its 50-day average ($0.88) and -45.0% vs its 200-day average ($1.47).
- 52-week range $0.67β$4.98; today's close sits at 3% of that range, 83.7% below the 52-week high.
- That makes 5 straight losses.
Oct 7, 2026 β FLNA slides 5.7% to $0.82, 4 down days in a row
- Closed at $0.82, -5.75% vs the prior close of $0.87. Day range $0.79β$0.85, opened at $0.85.
- Volume was 759.20K shares, 0.3x its 50-day average of 2.48M β lighter than usual.
- Price is -7.1% vs its 50-day average ($0.88) and -44.6% vs its 200-day average ($1.48).
- 52-week range $0.67β$4.98; today's close sits at 3% of that range, 83.5% below the 52-week high.
- That makes 4 straight losses.
Oct 6, 2026 β FLNA ends flat (+0.0%) to $0.87, 3 down days in a row
- Closed at $0.87, +0.00% vs the prior close of $0.87. Day range $0.83β$0.90, opened at $0.89.
- Volume was 670.00K shares, 0.3x its 50-day average of 2.47M β lighter than usual.
- Price is -1.5% vs its 50-day average ($0.88) and -41.6% vs its 200-day average ($1.49).
- 52-week range $0.67β$4.98; today's close sits at 5% of that range, 82.5% below the 52-week high.
- That makes 3 straight losses.
Oct 5, 2026 β FLNA slides 6.5% to $0.87
- Closed at $0.87, -6.45% vs the prior close of $0.93. Day range $0.87β$0.93, opened at $0.92.
- Volume was 1.03M shares, 0.4x its 50-day average of 2.46M β lighter than usual.
- Price is -1.6% vs its 50-day average ($0.88) and -42.0% vs its 200-day average ($1.50).
- 52-week range $0.67β$4.98; today's close sits at 5% of that range, 82.5% below the 52-week high.
Oct 2, 2026 β FLNA slides 4.1% to $0.93
- Closed at $0.93, -4.12% vs the prior close of $0.97. Day range $0.93β$1.04, opened at $0.97.
- Volume was 1.69M shares, 0.7x its 50-day average of 2.44M.
- Price is +5.1% vs its 50-day average ($0.88) and -38.4% vs its 200-day average ($1.51).
- 52-week range $0.67β$4.98; today's close sits at 6% of that range, 81.3% below the 52-week high.
FLNA latest news & SEC filings
Every SEC filing by or about FLNA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Barry Richard bought 206,813 shares at $0.90 (β$186.13K) on Sep 29, 2026; now holds 1,237,964
- Barry Richard bought 100,000 shares at $0.92 (β$92.00K) on Sep 30, 2026; now holds 1,337,964
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 30, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Barry Richard bought 93,091 shares at $0.84 (β$78.20K) on Sep 28, 2026; now holds 1,031,151
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 22, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
- Item 8.01 β Reported other events the company considers important.
Sep 18, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.01 β Stock exchange listing notice or transfer of listing.
Jul 29, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Jul 29, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Things to know before you trade FLNA
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Mar 12, 2026, Nov 12, 2025. Based on that rhythm, the next report is likely around Oct 28, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 7.28% (largest 39.2%). That is a volatile stock.
- Liquidity: about 5.84M shares (β$4.11M) trade per day on average.
- 52-week position: $0.70 vs a range of $0.67β$4.98 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 20 open-market buys, 0 sales; latest: Richard Barry bought 93,091 shares on Sep 28, 2026.
- Latest filings: 8-K Sep 22, 2026; 8-K Sep 18, 2026; 10-Q Jul 29, 2026.
- Share count: 48.31M shares outstanding (May 4, 2026), +0.0% vs a year earlier.
- Listing: Nasdaq Β· industry: Pharmaceutical Preparations.
FLNA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.75 | 0.76 | 0.70 | 0.70 | 327.93K |
| Oct 15, 2026 | 0.71 | 0.77 | 0.70 | 0.76 | 248.50K |
| Oct 14, 2026 | 0.73 | 0.74 | 0.72 | 0.73 | 253.20K |
| Oct 13, 2026 | 0.76 | 0.77 | 0.74 | 0.74 | 323.50K |
| Oct 12, 2026 | 0.81 | 0.81 | 0.76 | 0.77 | 360.40K |
| Oct 9, 2026 | 0.82 | 0.84 | 0.80 | 0.82 | 407.90K |
| Oct 8, 2026 | 0.80 | 0.82 | 0.78 | 0.81 | 610.80K |
| Oct 7, 2026 | 0.85 | 0.85 | 0.79 | 0.82 | 759.20K |
| Oct 6, 2026 | 0.89 | 0.90 | 0.83 | 0.87 | 670.00K |
| Oct 5, 2026 | 0.92 | 0.93 | 0.87 | 0.87 | 1.03M |
| Oct 2, 2026 | 0.97 | 1.04 | 0.93 | 0.93 | 1.69M |
| Oct 1, 2026 | 1.00 | 1.03 | 0.93 | 0.97 | 2.80M |
| Sep 30, 2026 | 0.93 | 0.95 | 0.86 | 0.89 | 769.50K |
| Sep 29, 2026 | 0.85 | 0.94 | 0.83 | 0.92 | 1.20M |
| Sep 28, 2026 | 0.73 | 0.89 | 0.72 | 0.85 | 2.05M |
| Sep 25, 2026 | 0.78 | 0.78 | 0.74 | 0.75 | 771.90K |
| Sep 24, 2026 | 0.85 | 0.90 | 0.74 | 0.77 | 2.31M |
| Sep 23, 2026 | 1.00 | 1.00 | 0.80 | 0.87 | 5.47M |
| Sep 22, 2026 | 0.98 | 1.30 | 0.90 | 1.03 | 94.30M |
| Sep 21, 2026 | 0.74 | 0.77 | 0.73 | 0.74 | 336.50K |
About Filana Therapeutics
Filana Therapeutics (FLNA) is listed on the Nasdaq and classified by the SEC under βPharmaceutical Preparationsβ. Its business address is in AUSTIN, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1069530.
FLNA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Robert Eugene Jr Anderson | Director | Nov 25, 2025 |
| Richard Barry | President & CEO | Sep 30, 2026 |
| Dawn Carter Bir | Director | Oct 22, 2025 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Richard Barry | President & CEO | Sep 30, 2026 |
| Robert Christopher Cook | Chief Operating & Legal Office | Oct 2, 2025 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 28, 2026 | Richard Barry | Buy | 93,091 | $0.84 |
| Sep 28, 2026 | Richard Barry | Buy | 93,091 | $0.84 |
| Sep 28, 2026 | Richard Barry | Buy | 93,091 | $0.84 |
| Sep 28, 2026 | Richard Barry | Buy | 93,091 | $0.84 |
| Nov 24, 2025 | Robert Eugene Jr Anderson | Buy | 8,600 | $2.90 |
| Nov 24, 2025 | Robert Eugene Jr Anderson | Buy | 8,600 | $2.90 |
| Nov 24, 2025 | Robert Eugene Jr Anderson | Buy | 8,600 | $2.90 |
| Nov 24, 2025 | Robert Eugene Jr Anderson | Buy | 8,600 | $2.90 |
| Nov 20, 2025 | Richard Barry | Buy | 150,000 | $2.76 |
| Nov 20, 2025 | Richard Barry | Buy | 150,000 | $2.76 |
| Nov 20, 2025 | Richard Barry | Buy | 150,000 | $2.76 |
| Nov 20, 2025 | Richard Barry | Buy | 150,000 | $2.76 |
| Nov 19, 2025 | Richard Barry | Buy | 73,385 | $2.75 |
| Nov 19, 2025 | Richard Barry | Buy | 73,385 | $2.75 |
| Nov 19, 2025 | Richard Barry | Buy | 73,385 | $2.75 |
FLNA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | β | $-90.97M | -1.88 | $-32.25M |
| Dec 31, 2024 | β | $-24.34M | -1.46 | $-116.93M |
| Dec 31, 2023 | β | $-97.22M | -2.32 | $-82.03M |
| Dec 31, 2022 | β | $-76.25M | -1.90 | $-77.51M |
| Dec 31, 2021 | β | $-32.38M | β | $-30.20M |
Latest balance sheet: total assets $108.37M, total liabilities $40.23M, cash $86.57M (as of Mar 31, 2026).
FLNA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $0.87 |
| May 7, 2026 | 8-K Item 2.02 (results) | $1.36 |
| Mar 12, 2026 | 8-K Item 2.02 (results) | $1.95 |
| Nov 12, 2025 | 8-K Item 2.02 (results) | $3.26 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $2.41 |
| May 8, 2025 | 8-K Item 2.02 (results) | $1.70 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $2.48 |
| Jan 7, 2025 | 8-K Item 2.02 (results) | $3.02 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $25.34 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | β |
| May 10, 2024 | 8-K Item 2.02 (results) | β |
| Feb 28, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on FLNA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.